This is an addendum to Int. J. Mol. Sci. 2010, 11(6), 2566-2575.

Int. J. Mol. Sci. 2010, 11(7), 2699-2700; doi:10.3390/ijms11072699
Addendum

Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575

1,2,* email, 3email and 1,2email
Received: 5 July 2010; Accepted: 8 July 2010 / Published: 12 July 2010
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: One additional skin lightening or whitening quasi-drug (QD) has been developed and officially approved by the Ministry of Health, Labor and Welfare of Japan.
PDF Full-text Download PDF Full-Text [23 KB, uploaded 19 June 2014 03:09 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Ando, H.; Matsui, M.S.; Ichihashi, M. Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575. Int. J. Mol. Sci. 2010, 11, 2699-2700.

AMA Style

Ando H, Matsui MS, Ichihashi M. Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575. International Journal of Molecular Sciences. 2010; 11(7):2699-2700.

Chicago/Turabian Style

Ando, Hideya; Matsui, Mary S.; Ichihashi, Masamitsu. 2010. "Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575." Int. J. Mol. Sci. 11, no. 7: 2699-2700.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert